Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$23.78
-0.9%
$25.48
$21.33
$40.49
$12.32B0.65.98 million shs7.04 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$185.90
-0.5%
$186.72
$163.33
$251.99
$53.55B0.271.67 million shs1.32 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$99.75
-2.9%
$104.78
$80.64
$109.50
$152.19B0.656.38 million shs12.02 million shs
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$13.91
+1.1%
$12.98
$8.48
$14.20
$30.74B0.8232,740 shs56,039 shs
Stryker Corporation stock logo
SYK
Stryker
$377.49
-1.5%
$388.68
$329.16
$406.19
$146.55B0.93974,703 shs843,029 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-0.92%-1.23%-1.74%-20.52%-40.13%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.71%-2.92%-5.09%+9.35%-20.61%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-2.88%-7.76%-3.30%-1.94%+19.73%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
+1.09%-0.43%+2.96%+12.54%+44.75%
Stryker Corporation stock logo
SYK
Stryker
-1.52%-3.98%-1.15%+1.11%+1.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$23.78
-0.9%
$25.48
$21.33
$40.49
$12.32B0.65.98 million shs7.04 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$185.90
-0.5%
$186.72
$163.33
$251.99
$53.55B0.271.67 million shs1.32 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$99.75
-2.9%
$104.78
$80.64
$109.50
$152.19B0.656.38 million shs12.02 million shs
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$13.91
+1.1%
$12.98
$8.48
$14.20
$30.74B0.8232,740 shs56,039 shs
Stryker Corporation stock logo
SYK
Stryker
$377.49
-1.5%
$388.68
$329.16
$406.19
$146.55B0.93974,703 shs843,029 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-0.92%-1.23%-1.74%-20.52%-40.13%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.71%-2.92%-5.09%+9.35%-20.61%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-2.88%-7.76%-3.30%-1.94%+19.73%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
+1.09%-0.43%+2.96%+12.54%+44.75%
Stryker Corporation stock logo
SYK
Stryker
-1.52%-3.98%-1.15%+1.11%+1.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.20
Hold$30.1126.62% Upside
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$211.4413.74% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
3.08
Buy$118.0418.34% Upside
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
3.33
BuyN/AN/A
Stryker Corporation stock logo
SYK
Stryker
2.78
Moderate Buy$431.4214.29% Upside

Current Analyst Ratings Breakdown

Latest BSX, BDX, BAX, SYK, and FSNUY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$121.00
9/8/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket PerformOutperform$118.00 ➝ $125.00
8/13/2025
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/11/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$196.00 ➝ $197.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$172.00 ➝ $184.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$185.00 ➝ $200.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$41.00 ➝ $36.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$35.00 ➝ $24.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyHold$36.00 ➝ $25.00
8/4/2025
Stryker Corporation stock logo
SYK
Stryker
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetHold$410.00 ➝ $415.00
8/1/2025
Baxter International Inc. stock logo
BAX
Baxter International
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$33.00 ➝ $24.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.15$4.71 per share5.05$13.76 per share1.73
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.18B2.64$21.03 per share8.84$89.57 per share2.08
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$16.75B8.83$3.54 per share28.14$14.93 per share6.68
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$23.63BN/A$1.30 per share10.66$9.83 per shareN/A
Stryker Corporation stock logo
SYK
Stryker
$22.60B6.39$14.85 per share25.42$54.13 per share6.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$0.30N/A8.710.78-1.42%16.96%5.24%11/14/2025 (Estimated)
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.5633.4411.891.517.51%16.23%7.46%11/6/2025 (Estimated)
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$1.85B$1.6859.3830.882.4713.55%19.21%10.62%10/22/2025 (Estimated)
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$509.67M$0.5326.2515.12N/A5.09%9.33%4.31%11/5/2025 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$2.99B$7.5550.0025.452.7612.25%23.94%11.08%11/4/2025 (Estimated)

Latest BSX, BDX, BAX, SYK, and FSNUY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q3 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.40$3.68+$0.28$1.99$5.50 billion$5.51 billion
8/6/2025Q2 2025
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$0.2182$0.24+$0.0218$0.16$5.83 billion$6.48 billion
7/31/2025Q2 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.60$0.59-$0.01$0.18$2.82 billion$2.81 billion
7/31/2025Q2 2025
Stryker Corporation stock logo
SYK
Stryker
$3.07$3.13+$0.06$2.29$5.92 billion$6.02 billion
7/23/2025Q2 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.72$0.75+$0.03$0.53$4.89 billion$5.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.86%N/AN/A N/A
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.24%N/A74.82%53 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$0.191.37%N/A35.85%N/A
Stryker Corporation stock logo
SYK
Stryker
$3.360.89%N/A44.50%32 Years

Latest BSX, BDX, BAX, SYK, and FSNUY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.840.88%9/30/20259/30/202510/31/2025
7/14/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.75%8/29/20258/29/202510/1/2025
7/22/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.17%9/8/20259/8/20259/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.30
2.30
1.49
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.10
0.62
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.49
1.37
0.82
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
0.49
1.31
1.00
Stryker Corporation stock logo
SYK
Stryker
0.70
1.78
1.06

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
N/A
Stryker Corporation stock logo
SYK
Stryker
77.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
38,000513.62 million512.59 millionOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.63 million285.60 millionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
53,0001.48 billion1.47 billionOptionable
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
176,486N/AN/ANot Optionable
Stryker Corporation stock logo
SYK
Stryker
53,000382.31 million362.43 millionOptionable

Recent News About These Companies

First Hawaiian Bank Sells 879 Shares of Stryker Corporation $SYK
Invst LLC Has $732,000 Position in Stryker Corporation $SYK
Stryker Corporation $SYK Shares Bought by Swedbank AB
Stryker Corporation $SYK Shares Purchased by Focus Partners Wealth
Great Lakes Advisors LLC Cuts Stake in Stryker Corporation $SYK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$23.78 -0.21 (-0.88%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$23.88 +0.09 (+0.40%)
As of 09/15/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$185.90 -0.94 (-0.50%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$184.86 -1.05 (-0.56%)
As of 09/15/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$99.75 -2.96 (-2.88%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$100.50 +0.75 (+0.75%)
As of 09/15/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Fresenius SE & Co. stock logo

Fresenius SE & Co. OTCMKTS:FSNUY

$13.91 +0.15 (+1.09%)
As of 09/15/2025 03:51 PM Eastern

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Stryker stock logo

Stryker NYSE:SYK

$377.49 -5.85 (-1.53%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$378.90 +1.41 (+0.37%)
As of 09/15/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.